3 completed. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
Follow OOS-A regimen: new trials by email Literature Review of OOS-A regimen trials Research Report on OOS-A regimen
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Randomized, Open-label, Single-dose, Single-center, Crossover Study in Healthy Subjects to Assess the Relative Bioavailability of PT010 Regimen A, Regimen B, Regimen C - Chronic Obstructive Pulmonary Disease | Phase 1 | Completed | Pearl Therapeutics, Inc. | 56 | 2017-10-17 | 2020-06-11 |
| A Comparison of the Bioavailability of OZ439 When Delivered Directly to the Small Intestine, or Via the Oral Route OZ439 120mg PIB, 120 mg OZ439 caplet, 120mg OZ439 caplet via Enterion capsule - Healthy Volunteers | Phase 1 | Completed | Medicines for Malaria Venture | 11 | 2012-11-01 | 2015-03-06 |
| An Open Label Study to Examine the Effects of a High-Fat Meal and Particle Size on the Pharmacokinetics of Orally Administered GSK2118436 in Subjects With BRAF Mutation Positive Tumor Regimen A, Regimen B, Regimen C - Cancer | Phase 1 | Completed | GlaxoSmithKline | 28 | 2010-10-21 | 2017-11-14 |
Neoplasms (1) · Pulmonary Disease, Chronic Obstructive (1)
GlaxoSmithKline (1) · Medicines for Malaria Venture (1) · Pearl Therapeutics, Inc. (1)
United States (2) · United Kingdom (1)
Fiona Macintyre, PhD (1) · Paul M. Dorinsky, MD (1)